The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Researchers Hone in on Defect in Autophagy that May Underlie Lupus

Researchers Hone in on Defect in Autophagy that May Underlie Lupus

June 13, 2016 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

CellsAbstract_HenrikJonsson_iStockphoto_500x270Every day, in each organism, millions of cells die and generate cell debris that must be efficiently and effectively removed via autophagy. This process is important, and genome-wide association studies have suggested that defects in autophagy are associated with inflammatory diseases, such as systemic lupus erythematosus (SLE) and Crohn’s disease. Further support of the role of autophagy in SLE pathogenesis comes from the fact that patients with lupus often have dead cells in their tissues. Scientists believe these dead cells trigger danger signals that can break tolerance and result in the generation of autoantibodies, such as the antibodies that are the hallmark of lupus. Likewise, researchers believe that if these dead cells could be cleared, then the danger signals would decrease, as would—possibly—the inflammation and pathology. New research takes this understanding to the next level, suggesting that successful autophagy is not just about whether or not the dead cells are taken up into phagosomes, but rather hinges on how the dead cells are processed.

You Might Also Like
  • Researchers Target Altered T Cell Metabolism in SLE to Reverse Lupus Immuno-Phenotype
  • Study Reveals Role of IL-17–Secreting CD4+ T Cells in Lupus
  • A Defect in Mitochondrial Function May Underlie Chronic Fatigue Syndrome
Also By This Author
  • Updated OARSI Guideline for the Non-Surgical Management of Osteoarthritis

Jennifer Martinez, PhD, head of the Inflammation and Autoimmunity Group at the National Institute of Environmental Health Sciences, Research Triangle Park, N.C., and colleagues published the results of their investigation of the role of autophagy in lupus online on April 20 in Nature.1 They focused their effort on the cell digestion process known as LC3-associated phagocytosis (LAP). “The dogma for a long time has been that, if you can eat a cell, you can get rid of a cell,” explains Dr. Martinez in an interview with The Rheumatologist.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Her group looked at that assumption closely and focused their efforts on the LAP step of the dead cell clearance pathway. “LAP is somewhat of a rapid process,” she explains, adding, “It generally acts to inhibit inflammation.” The investigators studied LAP-deficient mice that develop an autoinflammatory, lupus-like syndrome. They found that defects in LAP, as opposed to defects in canonical autophagy, can cause SLE-like pathogenesis.

The investigators then asked whether repeated injection of apoptotic thymocytes could exacerbate the SLE-like phenotype seen in LAP-deficient mice. They found that repeated injection of dying cells into LAP-deficient mice (as opposed to LAP-sufficient mice) accelerated the development of SLE-like disease. In contrast, injection of dying cells into mice that were deficient for genes required for canonical autophagy did not result in defective clearance of dying cells, inflammatory cytokine production or SLE-like disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

When the researchers examined spontaneous cytokine production in LAP-deficient and LAP-sufficient mice, they found that genotypes lacking LAP had increased levels of IL-1β, IL-6, IL-12p40 and IP-10 when compared with mice that produced LAP. The LAP-deficient mice also produced significantly lower levels of IL-10 than controls. The last observation is consistent with previous studies that have shown that mice lacking IL-10 experience markedly accelerated lupus-like disease.

Pages: 1 2 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Autophagy, cell death, Lupus, systemic lupus erythematosus (SLE)

You Might Also Like:
  • Researchers Target Altered T Cell Metabolism in SLE to Reverse Lupus Immuno-Phenotype
  • Study Reveals Role of IL-17–Secreting CD4+ T Cells in Lupus
  • A Defect in Mitochondrial Function May Underlie Chronic Fatigue Syndrome
  • Bacterial Curli Amyloid: Researchers Examine the Role of Bacterial Infection in Lupus Pathology

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.